Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Semarion

Product to watch - SemaCyte® Multiplexing Platform

Portfolio company Semarion's SemaCyte® Multiplexing Platform was listed as one of the "Products to Watch" in Genetic Engineering & Biotechnology News.

In the May edition of Genetic Engineering & Biotechnology News, portfolio company Semarion's SemaCyte® Multiplexing Platform was listed as one of the "Products to Watch".

The SemaCyte Multiplexing Platform builds on the existing SemaCyte Microcarrier platform to enable optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes.

Learn more about Semarion here: https://rb.gy/ldkc7g